Sunday, October 28, 2012

Where NY-22 candidates Richard Hanna and Dan Lamb stand on the issues

The economy

Lamb: Lamb says he wants to crack down on China’s currency manipulation and reform unfair trade arrangements “so that we export our products instead of our jobs.” He supports federal investment in high-tech research to incubate new industries in solar energy and other green technology. He opposes NAFTA, the North American Free Trade Agreement, and says it cost the U.S. 700,000 jobs.

Hanna: Hanna blames “high taxes, excess regulation, economic decay and an unaccountable government” for hurting Upstate New York’s economy. He voted for free trade agreements with South Korea, Colombia and Panama and says they will help open new markets for Upstate agriculture and manufacturers.

Tax cuts

Lamb: Supports extending the Bush-era federal tax cuts for those earning less than $250,000 per year. He says the tax cuts should be allowed to expire on Jan. 1 for individuals earning more than $250,000. Lamb says the new revenue would reduce the deficit by $800 billion and prevent a tax increase on middle-class families.

Hanna: Supports extending the Bush-era tax cuts from 2001 and 2003 for those earning less than $500,000 per year. He says the tax cuts should be allowed to expire on Jan. 1 for individuals earning more than $500,000. He says the $250,000 limit favored by President Obama would hurt small business owners in Central New York.

Medicare

Lamb: He opposes the Republican plan to reform Medicare for future recipients, saying it is wrong to issue government vouchers or ask seniors to purchase their own private insurance. He says the GOP plan would force seniors to pay an additional $6,000 per year for their health care costs.

Hanna: Opposes Rep. Paul Ryan’s plan that encourages seniors to buy private health insurance, but he voted for the overall Ryan budget that included those Medicare changes. He says Medicare reform should have been a priority over the Affordable Care Act. He wants to reduce costs through actions such as medical liability reform and negotiating prescription drug prices.

Complete Post

No comments: